(Q37603085)

21 August 2017

1 reference

title

The pathological spectrum of CNS inflammatory demyelinating diseases (English)

1 reference

21 August 2017

0 references

Wei Hu

1

1 reference

PubMed ID

19779719

21 August 2017

Claudia F Lucchinetti

series ordinal

2

1 reference

21 August 2017

25 September 2009

1 reference

Seminars in Immunopathology

21 August 2017

1 reference

21 August 2017

31

1 reference

21 August 2017

4

1 reference

21 August 2017

439-453

1 reference

https://scigraph.springernature.com/pub.10.1007/s00281-009-0178-z

21 August 2017

0 references

cites work

Incidence and prevalence of multiple sclerosis in Olmsted County, Minnesota, 1985-2000.

1 reference

https://api.crossref.org/works/10.1007%2FS00281-009-0178-Z

Preferential loss of myelin-associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-009-0178-Z

Expression of chemokine receptors CCR1 and CCR5 reflects differential activation of mononuclear phagocytes in pattern II and pattern III multiple sclerosis lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-009-0178-Z

Subpial demyelination in the cerebral cortex of multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-009-0178-Z

ENCEPHALITIS PERIAXIALIS CONCENTRICA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-009-0178-Z

Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-009-0178-Z

The open ring. A new imaging sign in demyelinating disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-009-0178-Z

The clinical course of neuromyelitis optica (Devic's syndrome).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-009-0178-Z

Oligoclonal myelin-reactive T-cell infiltrates derived from multiple sclerosis lesions are enriched in Th17 cells.

21 January 2018

1 reference

12 December 2020

Revised estimate of the prevalence of multiple sclerosis in the united states

1 reference

12 December 2020

The relation between inflammation and neurodegeneration in multiple sclerosis brains.

1 reference

12 December 2020

Large focal tumor-like demyelinating lesions of the brain: intermediate entity between multiple sclerosis and acute disseminated encephalomyelitis? A study of 31 patients

1 reference

12 December 2020

The role of aquaporin-4 in the blood-brain barrier development and integrity: studies in animal and cell culture models.

1 reference

12 December 2020

Acquired inflammatory white matter disease

1 reference

12 December 2020

Immunopathology of secondary-progressive multiple sclerosis.

1 reference

12 December 2020

Balò's concentric sclerosis: MRI.

1 reference

12 December 2020

Spinal cord neuronal pathology in multiple sclerosis.

1 reference

12 December 2020

Devic's neuromyelitis optica: a clinicopathological study of 8 patients.

1 reference

12 December 2020

IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel

1 reference

12 December 2020

The natural history of multiple sclerosis

1 reference

12 December 2020

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

1 reference

12 December 2020

Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression

1 reference

12 December 2020

Homogeneity of active demyelinating lesions in established multiple sclerosis

1 reference

12 December 2020

Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration

1 reference

12 December 2020

Absence of aquaporin-4 expression in lesions of neuromyelitis optica but increased expression in multiple sclerosis lesions and normal-appearing white matter

1 reference

12 December 2020

Non-MS recurrent demyelinating diseases

1 reference

12 December 2020

Loss of aquaporin-4 in active perivascular lesions in neuromyelitis optica: a case report

1 reference

12 December 2020

Altered Glutamate Reuptake in Relapsing-Remitting and Secondary Progressive Multiple Sclerosis Cortex: Correlation With Microglia Infiltration, Demyelination, and Neuronal and Synaptic Damage

1 reference

12 December 2020

Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion

1 reference

12 December 2020

Evidence for pathogenic heterogeneity in multiple sclerosis

1 reference

12 December 2020

Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders

1 reference

12 December 2020

Concentric sclerosis (Baló): morphometric and in situ hybridization study of lesions in six patients.

1 reference

12 December 2020

Characterization of tumefactive demyelinating lesions using MR imaging and in-vivo proton MR spectroscopy

1 reference

12 December 2020

The pathology of multiple sclerosis: evidence for heterogeneity.

1 reference

12 December 2020

Immunoglobulins and complement in postmortem multiple sclerosis tissue

1 reference

12 December 2020

The clinical course of acute disseminated encephalomyelitis

1 reference

12 December 2020

Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis

1 reference

12 December 2020

Normal-appearing white matter in multiple sclerosis is in a subtle balance between inflammation and neuroprotection

1 reference

12 December 2020

Widespread demyelination in the cerebellar cortex in multiple sclerosis.

1 reference

12 December 2020

Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions.

1 reference

12 December 2020

Grey matter pathology in multiple sclerosis

1 reference

12 December 2020

Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis

1 reference

12 December 2020

Multiple sclerosis: recent developments in neuropathology, pathogenesis, magnetic resonance imaging studies and treatment

1 reference

12 December 2020

Cortical demyelination and diffuse white matter injury in multiple sclerosis.

1 reference

12 December 2020

Gray matter involvement in multiple sclerosis

1 reference

12 December 2020

Devic's neuromyelitis optica: clinical, laboratory, MRI and outcome profile.

1 reference

12 December 2020

Tissue preconditioning may explain concentric lesions in Baló's type of multiple sclerosis.

1 reference

12 December 2020

Neocortical neuronal, synaptic, and glial loss in multiple sclerosis.

1 reference

12 December 2020

Grey Matter Pathology in Multiple Sclerosis

1 reference

12 December 2020

Monocyte/macrophage differentiation in early multiple sclerosis lesions.

1 reference

12 December 2020

Identification of autoantibodies associated with myelin damage in multiple sclerosis

1 reference

12 December 2020

A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica

1 reference

12 December 2020

Open-ring imaging sign: highly specific for atypical brain demyelination

1 reference

12 December 2020

Tumor-like multiple sclerosis (MS) lesions: neuropathological clues

1 reference

12 December 2020

A defect of sphingolipid metabolism modifies the properties of normal appearing white matter in multiple sclerosis

1 reference

12 December 2020

Post-infectious encephalomyelitis and multiple sclerosis; the significance of perivenous encephalomyelitis

1 reference

12 December 2020

Extensive cortical inflammation is associated with epilepsy in multiple sclerosis

1 reference

12 December 2020

Cortical demyelination in PML and MS: Similarities and differences

1 reference

12 December 2020

Baló's concentric sclerosis: clinical and radiologic features of five cases

1 reference

12 December 2020

Imaging axonal damage of normal-appearing white matter in multiple sclerosis.

1 reference

12 December 2020

Regional variations in the extent and pattern of grey matter demyelination in multiple sclerosis: a comparison between the cerebral cortex, cerebellar cortex, deep grey matter nuclei and the spinal cord

1 reference

12 December 2020

Multiple sclerosis and Alzheimer's disease

1 reference

12 December 2020

Mitochondrial defects in acute multiple sclerosis lesions

1 reference

12 December 2020

Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis.

1 reference

12 December 2020

Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis.

1 reference

12 December 2020

The spectrum of neuromyelitis optica

1 reference

12 December 2020

Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain

1 reference

12 December 2020

Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity?

1 reference

12 December 2020

The blood-brain barrier in cortical multiple sclerosis lesions

1 reference

12 December 2020

An alpha-syntrophin-dependent pool of AQP4 in astroglial end-feet confers bidirectional water flow between blood and brain

1 reference

12 December 2020

Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology.

1 reference

12 December 2020

Evidence for relative cortical sparing in benign multiple sclerosis: a longitudinal magnetic resonance imaging study.

1 reference

12 December 2020

Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange

1 reference

12 December 2020

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis

1 reference

12 December 2020

Extensive cortical remyelination in patients with chronic multiple sclerosis.

1 reference

12 December 2020

Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2.

1 reference

12 December 2020

Acute demyelinating disease. Classification and non-invasive diagnosis

1 reference

12 December 2020

Pathological abnormalities in the normal-appearing white matter in multiple sclerosis

1 reference

12 December 2020

Cortical lesions in multiple sclerosis

1 reference

12 December 2020

Molecular changes in normal appearing white matter in multiple sclerosis are characteristic of neuroprotective mechanisms against hypoxic insult

1 reference

12 December 2020

Greater loss of axons in primary progressive multiple sclerosis plaques compared to secondary progressive disease.

1 reference

12 December 2020

Abnormalities in the macroscopically normal white matter in cases of mild or spinal multiple sclerosis (MS)

1 reference

12 December 2020

Postinfectious encephalomyelitis

1 reference

12 December 2020

Multiple sclerosis: relevance of class I and class II MHC-expressing cells to lesion development.

1 reference

12 December 2020

Devic's neuromyelitis optica: study of nine cases

1 reference

12 December 2020

Haemorrhagic and perivenous encephalitis: a clinical-pathological review of 38 cases

1 reference

12 December 2020

Fulminant tumefactive multiple sclerosis: therapeutic implications of histopathology

1 reference

12 December 2020

Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination.

1 reference

12 December 2020

10.1007/S00281-009-0178-Z

Identifiers

DOI

1 reference

21 August 2017

1 reference

PubMed ID

19779719